Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001991 · ClinicalTrials.gov registry record · NA
A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia
A NA study, sponsored by Glaxo Wellcome.
- Completed
- Registry status
- NA
- Development phase
NCT00001991: Completed NA study, sponsored by Glaxo Wellcome.
NCT00001991 is a NA study that has completed, run by Glaxo Wellcome. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001991, a NA study, has completed, sponsored by Glaxo Wellcome.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To facilitate provision of atovaquone (566C80) to patients who have mild to moderate Pneumocystis carinii pneumonia (PCP) and are intolerant and/or unresponsive to trimethoprim / sulfamethoxazole (TMP / SMX ); to monitor serious adverse events attributable to 566C80.
Interventions
- DRUG Atovaquone
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00001991 record still lists
NCT00001991 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Atovaquone is the first listed.
NCT00001991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001991 about?
NCT00001991 is a clinical study titled "A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia". To facilitate provision of atovaquone (566C80) to patients who have mild to moderate Pneumocystis carinii pneumonia (PCP) and are intolerant and/or unresponsive to trimethoprim / sulfamethoxazole (TMP / SMX ); to monitor serious adverse events attributable to 566C80.
What is the current status of trial NCT00001991?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00001991?
The interventions under investigation include: Atovaquone (DRUG).
Who is sponsoring clinical trial NCT00001991?
This trial is sponsored by Glaxo Wellcome, which has 65 total clinical trials registered on ClinicalTrials.gov.